Skip to main content
HANGZHOU AGS MEDTECH CO.,LTD logo

HANGZHOU AGS MEDTECH CO.,LTD — Investor Relations & Filings

Ticker · 688581 ISIN · CNE100005ZF0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2025-04-29 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688581

About HANGZHOU AGS MEDTECH CO.,LTD

http://www.bioags.com/en/index.aspx

Hangzhou AGS MedTech Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical instruments, primarily focusing on endoscopic accessories. The product portfolio encompasses a comprehensive range of disposable devices for gastrointestinal and respiratory interventions, including biopsy forceps, hemoclips, injection needles, polypectomy snares, and guide wires. The company integrates advanced manufacturing processes with rigorous quality management systems, adhering to international standards such as ISO 13485, CE, and FDA. By providing high-precision diagnostic and therapeutic tools, the organization supports clinical procedures in gastroenterology and pulmonology. Its technical expertise facilitates the delivery of reliable solutions aimed at improving procedural outcomes and patient safety in global healthcare markets.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于杭州安杰思医学科技股份有限公司2024年度持续督导工作现场检查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "现场检查报告" (on-site inspection report) by the sponsor (中信证券股份有限公司) regarding the continuous supervision work for the year 2024 of 杭州安杰思医学科技股份有限公司. It details the sponsor's on-site inspection activities, including governance, internal controls, information disclosure, independence, use of raised funds, related party transactions, guarantees, major investments, and operational status. The document is a detailed report of the sponsor's supervisory inspection findings and opinions, not an announcement or a brief summary. It is not an annual report, interim report, earnings release, or any other financial statement type. It is also not a regulatory filing or announcement but a formal inspection report by the sponsor. This type of document fits best under the category of Audit Report / Information (AR), as it is a standalone report on internal controls, compliance, and supervisory inspection results, excluding full annual reports. The document length is 3050 characters, which is relatively short but contains substantive content and detailed findings, not just an announcement or certification. Therefore, the classification is AR with high confidence. FY 2024
2025-04-29 Chinese
中信证券股份有限公司关于杭州安杰思医学科技股份有限公司2024年度持续督导跟踪报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2024年度持续督导跟踪报告" (2024 Annual Continuous Supervision Follow-up Report) issued by the sponsor (中信证券股份有限公司) for 杭州安杰思医学科技股份有限公司. It references continuous supervision duties under securities issuance and listing regulations, including review of governance, financial controls, audit reports, fundraising usage, and risk factors. The document contains detailed financial data for 2024, risk assessments, R&D progress, and compliance with fundraising usage. It is a comprehensive supervisory report by the sponsor, not a full annual report by the company itself, nor a simple announcement. It is a standalone audit/supervisory report related to regulatory compliance and ongoing sponsor duties, fitting the definition of an Audit Report / Information (AR). The document length and content confirm it is not a brief announcement or certification, but a substantive report. Therefore, the classification is AR with high confidence. FY 2024
2025-04-29 Chinese
安杰思2024年度独立董事述职报告-吴建海
Management Reports Classification · 95% confidence The document is titled '2024年度独立董事述职报告' which translates to '2024 Annual Independent Director's Work Report'. It details the independent director's background, attendance at board and committee meetings, oversight activities, and opinions on company governance and financial reporting for the year 2024. The content focuses on the independent director's duties, observations, and evaluations rather than presenting full financial statements or audit results. It is a report on management and governance activities rather than a formal audit report or annual report. Therefore, it fits best under the category of Management Reports (MDA), which covers management's detailed explanation of business trends, governance, and oversight activities.
2025-04-22 Chinese
安杰思2024年度会计师事务所职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled '2024年度会计师事务所履职情况评估报告' which translates to '2024 Annual Evaluation Report on the Performance of the Accounting Firm.' It discusses the audit firm's background, its performance, legal and regulatory compliance, and the audit work done for the company's 2024 financial report. The document includes detailed information about the audit firm, its independence, audit procedures, and communication with the audit committee and management. It is a standalone report focused on the audit firm's performance and audit results, not the full annual report or financial statements themselves. This matches the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles. The document length is over 6000 characters, indicating it is a full report rather than a brief announcement. Therefore, the correct classification is AR with high confidence. FY 2024
2025-04-22 Chinese
安杰思第三届第二次职工代表大会决议公告
Board/Management Information Classification · 95% confidence The document is an announcement from Hangzhou Anjiesi Medical Technology Co., Ltd. regarding the resolution of the third second employee representative meeting held on April 21, 2025. It discusses the approval of the 2025 employee stock ownership plan draft and the election of employee representative directors and supervisors. The document includes legal compliance statements and details about the election results and the plan's benefits. It is a formal announcement of meeting resolutions related to employee stock plans and board representation, not a full report or financial statement. The document length is short (1180 characters), and it is clearly an announcement of meeting resolutions rather than a detailed report or presentation. Therefore, it fits best under the category of Board/Management Information (MANG), as it announces changes in board composition and management-related decisions.
2025-04-22 Chinese
安杰思关于续聘会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the reappointment of an accounting firm (Tianjian CPA Firm) as the company's auditor for the fiscal year 2025. It details the auditor's qualifications, past litigation, independence, and audit fees, and mentions that the appointment is subject to shareholder approval at the upcoming annual general meeting. The document does not contain any financial statements or audit reports themselves, but rather is a formal announcement of the auditor appointment process and related information. The document length is about 3,000 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best into the category of Regulatory Filings (RNS) as it is a regulatory announcement about auditor appointment rather than the audit report or annual report itself.
2025-04-22 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.